TY - JOUR
T1 - Classification of death causes after transplantation (CLASS) evaluation of methodology and initial results
AU - Wareham, Neval Ete
AU - Da Cunha-Bang, Caspar
AU - Borges, Álvaro H.
AU - Ekenberg, Christina
AU - Gerstoft, Jan
AU - Gustafsson, Finn
AU - Hansen, Ditte
AU - Heilmann, Carsten
AU - Helleberg, Marie
AU - Hillingsø, Jens
AU - Krohn, Paul Suno
AU - Lodding, Isabelle Paula
AU - Lund, Thomas Kromann
AU - Lundgren, Louise
AU - Mocroft, Amanda
AU - Perch, Michael
AU - Petersen, Søren Lykke
AU - Petruskevicius, Irma
AU - Rasmussen, Allan
AU - Rossing, Kasper
AU - Rostved, Andreas A.
AU - Sengeløv, Henrik
AU - Sørensen, Vibeke Rømming
AU - Sørensen, Søren Schwartz
AU - Lundgren, Jens D.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Correct classification of death causes is an important component of transplant trials. We aimed to develop and validate a system to classify causes of death in hematopoietic stem cell (HSCT) and solid organ (SOT) transplant recipients. Case record forms (CRF) of fatal cases were completed, including investigator-designated cause of death. Deaths occurring in 2010 to 2013 were used for derivation; and were validated by deaths occurring in 2013 to 2015. Underlying cause of death (referred to as recorded underlying cause) was determined through a central adjudication process involving 2 external reviewers, and subsequently compared with the Danish National Death Cause Registry. Three hundred eighty-eight recipients died 2010 to 2015 (196 [51%] SOT and 192 [49%] HSCT). The main recorded underlying causes of death among SOT and HSCT were classified as cancer (20%, 48%), graft rejection/failure/graft-versus-host-disease (35%, 28%), and infections (20%, 11%). Kappa between the investigator-designated and the recorded underlying cause of death was 0.74 (95% CI 0.69-0.80) in derivation and comparable in the validation cohort. Death causes were concordant with the Danish National Death Cause Registry in 37.2% (95% CI 31.5-42.9) and 38.4% (95% CI 28.8-48.0) in the derivation and validation cohorts, respectively. We developed and validated a method to systematically and reliably classify the underlying cause of death among transplant recipients. There was a high degree of discordance between this classification and that in the Danish National Death Cause Registry.
AB - Correct classification of death causes is an important component of transplant trials. We aimed to develop and validate a system to classify causes of death in hematopoietic stem cell (HSCT) and solid organ (SOT) transplant recipients. Case record forms (CRF) of fatal cases were completed, including investigator-designated cause of death. Deaths occurring in 2010 to 2013 were used for derivation; and were validated by deaths occurring in 2013 to 2015. Underlying cause of death (referred to as recorded underlying cause) was determined through a central adjudication process involving 2 external reviewers, and subsequently compared with the Danish National Death Cause Registry. Three hundred eighty-eight recipients died 2010 to 2015 (196 [51%] SOT and 192 [49%] HSCT). The main recorded underlying causes of death among SOT and HSCT were classified as cancer (20%, 48%), graft rejection/failure/graft-versus-host-disease (35%, 28%), and infections (20%, 11%). Kappa between the investigator-designated and the recorded underlying cause of death was 0.74 (95% CI 0.69-0.80) in derivation and comparable in the validation cohort. Death causes were concordant with the Danish National Death Cause Registry in 37.2% (95% CI 31.5-42.9) and 38.4% (95% CI 28.8-48.0) in the derivation and validation cohorts, respectively. We developed and validated a method to systematically and reliably classify the underlying cause of death among transplant recipients. There was a high degree of discordance between this classification and that in the Danish National Death Cause Registry.
KW - Cancer
KW - Infection
KW - Methodology
KW - Transplantation death causes classification
UR - https://www.scopus.com/pages/publications/85050694154
U2 - 10.1097/MD.0000000000011564
DO - 10.1097/MD.0000000000011564
M3 - Article
C2 - 30024557
AN - SCOPUS:85050694154
SN - 0025-7974
VL - 97
JO - Medicine (United States)
JF - Medicine (United States)
IS - 29
M1 - e11564
ER -